Dakota Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Dakota Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Sell	38,103 -1,730	-4%	-$99.3K	0.04%	295
2026 Q1	$2.42M	Sell	39,833 -4,482	-10%	-$261K	0.05%	256
2025 Q4	$2.39M	Sell	44,315 -5,904	-12%	-$284K	0.04%	262
2025 Q3	$2.26M	Sell	50,219 -9,659	-16%	-$451K	0.05%	238
2025 Q2	$2.77M	Sell	59,878 -218,671	-79%	-$10.7M	0.06%	222
2025 Q1	$17M	Buy	278,549 +18,256	+7%	+$1.06M	0.4%	51
2024 Q4	$14.7M	Buy	260,293 +205,772	+377%	+$11.5M	0.34%	62
2024 Q3	$2.82M	Sell	54,521 -1,644	-3%	-$77.1K	0.06%	230
2024 Q2	$2.33M	Buy	56,165 +9,748	+21%	+$436K	0.05%	242
2024 Q1	$2.52M	Buy	46,417 +27,158	+141%	+$1.38M	0.06%	236
2023 Q4	$988K	Sell	19,259 -4,561	-19%	-$239K	0.04%	312
2023 Q3	$1.38M	Sell	23,820 -3,418	-13%	-$209K	0.06%	245
2023 Q2	$1.74M	Buy	27,238 +713	+3%	+$47.8K	0.08%	199
2023 Q1	$1.84M	Sell	26,525 -5,375	-17%	-$379K	0.12%	161
2022 Q4	$2.3M	Sell	31,900 -8,734	-21%	-$659K	0.16%	139
2022 Q3	$2.89M	Buy	40,634 +19,225	+90%	+$1.39M	0.23%	104
2022 Q2	$1.65M	Buy	21,409 +16,869	+372%	+$1.28M	0.15%	145
2022 Q1	$332K	Buy	+4,540	New	+$305K	0.03%	347
2021 Q2	–	Sell	-11,387	Closed	-$719K	–	336
2021 Q1	$719K	Sell	11,387 -318	-3%	-$19.8K	0.09%	175
2020 Q4	$726K	Buy	+11,705	New	+$720K	0.09%	177
2019 Q1	–	Sell	-5,570	Closed	-$339K	–	304
2018 Q4	$339K	Sell	5,570 -201	-3%	-$10.8K	0.08%	203
2018 Q3	$359K	Buy	5,771 +356	+7%	+$21.1K	0.08%	190
2018 Q2	$299K	Buy	+5,415	New	+$292K	0.08%	166

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dakota Wealth Management's BMY Position: Q2 2026 in Review

Dakota Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, selling an estimated $99.3K and leaving 38,103 shares worth $2.2M. The position accounts for 0.04% of the portfolio, ranked #295.

Dakota Wealth Management first reported a position in BMY in Q2 2018 and has held it in 23 quarters since. The position peaked at $17M in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Dakota Wealth Management held 38,103 shares of Bristol-Myers Squibb worth $2.2M as of Q2 2026.
Dakota Wealth Management sold 1,730 Bristol-Myers Squibb shares in Q2 2026, an estimated $99.3K.
Bristol-Myers Squibb made up 0.04% of Dakota Wealth Management's portfolio in Q2 2026, its #295 holding.
Dakota Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 23 quarters since.
Dakota Wealth Management's Bristol-Myers Squibb position peaked at $17M in Q1 2025.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.